Low-grade endometrial endometrioid carcinoma of the p53-abnormal group: case presentation and diagnostic issues
Pathologica · 2024
DOI: 10.32074/1591-951x-1044 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pathologica, 2024. Verfasst von Susanna Ronchi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Unit, Department of Oncology, ASST Sette Laghi, Varese, Italy. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Tumor Suppressor Protein p53, Carcinoma, Endometrioid. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
P53-abnormal endometrial carcinomas are high-grade and aggressive tumors which should be treated with chemo-/radiotherapy. In low-grade endometrioid carcinoma (LGEC), abnormal expression of p53 is an exceptional finding and is typically accompanied by patchy p16 positivity and diffuse hormone receptor expression. Herein, we report a case of LGEC exhibiting both p53 and p16 overexpression, highlighting the diagnostic pitfalls related to such phenotype. A 60-year-old woman underwent hysterectomy and bilateral salpingo-oophorectomy with pelvic lymphadenectomy due to a deeply myoinvasive endometrial mass. The tumor showed glandular architecture, low-grade nuclei and glandular differentiation. Focal lymphovascular space invasion and no lymph node metastases were observed. Immunohistochemically, the tumor showed p53 overexpression, p16 block-type positivity, diffuse hormone receptors positivity and retained mismatch repair proteins expression. No POLE mutations were identified. A diagnosis of p53-abnormal LGEC was eventually made. A glandular neoplasm with p53 and/or p16-overexpression on endometrial biopsy specimens may raise the concern of other entities such as serous carcinoma, HPV-related endocervical adenocarcinoma, and gastric-type adenocarcinoma. An immunohistochemical panel including hormone receptors, p53, p16 and mismatch repair proteins appears necessary for an accurate diagnosis of uterine adenocarcinomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology Unit, Department of Oncology, ASST Sette Laghi, Varese, Italy.
- Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
- Gynecology and Obstetrics Unit, Department of Neurosciences, Reproductive Sciences and Dentistry, University of Naples "Federico II", Naples, Italy.
- Gynecology Unit, Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy.
- Pathology Unit, Department of Woman and Child's Health and Public Health Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
- Pathology Institute, Catholic University of Sacred Heart, Rome, Italy.
Zitieren
APA
Ronchi, S., Di Lauro, E., Facco, C., Raffone, A., Fulgione, C., Casarin, J., Santoro, A., Arciuolo, D., Angelico, G., Zannoni, G. F., La Rosa, S., & Travaglino, A. (2024). Low-grade endometrial endometrioid carcinoma of the p53-abnormal group: case presentation and diagnostic issues. Pathologica. https://doi.org/10.32074/1591-951x-1044
Vancouver
Ronchi S, Di Lauro E, Facco C, Raffone A, Fulgione C, Casarin J, et al. Low-grade endometrial endometrioid carcinoma of the p53-abnormal group: case presentation and diagnostic issues. Pathologica. 2024. doi:10.32074/1591-951x-1044
BibTeX
@article{Ronchi2024,
author = {Ronchi, Susanna and Di Lauro, Eleonora and Facco, Carla and Raffone, Antonio and Fulgione, Caterina and Casarin, Jvan and Santoro, Angela and Arciuolo, Damiano and Angelico, Giuseppe and Zannoni, Gian Franco and La Rosa, Stefano and Travaglino, Antonio},
title = {Low-grade endometrial endometrioid carcinoma of the p53-abnormal group: case presentation and diagnostic issues},
journal = {Pathologica},
year = {2024},
doi = {10.32074/1591-951x-1044}
}
EUVIMED